| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 04/08/2010 | US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 04/08/2010 | US20100087446 2-substituted indole derivatives as calcium channel blockers |
| 04/08/2010 | US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/08/2010 | US20100087320 Arylphenyl-substituted cyclic keto-enols |
| 04/08/2010 | US20100086881 Oxime ester photoinitiators |
| 04/08/2010 | DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors |
| 04/08/2010 | CA2738799A1 Antioxidant compounds and methods of their use |
| 04/08/2010 | CA2738694A1 Compounds derived from 2-(3-methylenedioxy)-benzoyl indol |
| 04/08/2010 | CA2738314A1 1,2-benzisothiazolinone and isoindolinone derivatives |
| 04/07/2010 | EP2172455A1 Oxime ester photoinitiators |
| 04/07/2010 | EP2172454A1 Benzimidazole derivative |
| 04/07/2010 | EP2172453A1 COMPOUND HAVING 11 ß-HSD1 INHIBITORY ACTIVITY |
| 04/07/2010 | EP2172450A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 04/07/2010 | EP2172447A1 Amide compound |
| 04/07/2010 | EP2170827A2 Indolin-2-ones and aza-indolin-2-ones |
| 04/07/2010 | EP2170826A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 04/07/2010 | EP2170825A2 Substituted indoles |
| 04/07/2010 | EP2170824A1 Novel process |
| 04/07/2010 | EP2170823A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 04/07/2010 | EP2170065A1 Diphenyl substituted alkanes |
| 04/07/2010 | EP1934179B1 Processes and intermediates |
| 04/07/2010 | EP1635818B1 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/07/2010 | CN101691350A Method for preparing N-methylol-3,4,5,6-tetrahydrophthalimide |
| 04/07/2010 | CN101691349A Process for extracting tryptophan from fermentation liquid |
| 04/07/2010 | CN101139315B Method for preparing di(N-methyl phthalimide) ether |
| 04/06/2010 | US7691968 Process for the synthesis of peptides amides by side-chain attachment to a solid phase |
| 04/06/2010 | US7691920 Ink jet of functionalized waxes |
| 04/06/2010 | US7691895 3'-{N'-[1-(3,4-Dimethyl-phenyl)-2-oxo-1,2-dihydro-indol-3-ylidene]-hydrazino}-2'-hydroxy-biphenyl-3-carboxylic acid; receptor agonist; drug screening; thrombocytopenia |
| 04/06/2010 | US7691894 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 04/06/2010 | US7691893 Chemical compounds |
| 04/06/2010 | US7691491 high durability, prepared at low cost; optical output with an extremely high efficiency and a high luminance; good luminescence hue of extremely high purity |
| 04/06/2010 | CA2533005C Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 04/06/2010 | CA2416220C Preparation of phosphatase inhibitors |
| 04/06/2010 | CA2358505C Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 04/01/2010 | WO2010035032A1 Calcium ion channel modulators & uses thereof |
| 04/01/2010 | WO2010034118A1 Nitric oxide releasing amino acid ester compound, composition and method of use |
| 04/01/2010 | WO2010008864A3 Cycloalkane[b]indole angtagonists of prostaglandin d2 receptors |
| 04/01/2010 | WO2009148654A3 Cephalotaxus esters, methods of synthesis, and uses thereof |
| 04/01/2010 | US20100081829 Method for producing phenolphthalein using a heteropolyacid catalyst |
| 04/01/2010 | US20100081828 Catalytic method for producing phenolphthalein compounds |
| 04/01/2010 | US20100081699 Yeast platform construction and screening methods |
| 04/01/2010 | US20100081696 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 04/01/2010 | US20100081610 Matrix metalloproteinase inhibitors |
| 04/01/2010 | US20100080758 Optical fluorescent imaging |
| 04/01/2010 | US20100080733 Needle assembly for aspirating and dispensing from sealed containers |
| 04/01/2010 | CA2775370A1 Nitric oxide releasing amino acid ester compound, composition and method of use |
| 03/31/2010 | EP2167465A1 Indolinone derivatives and their use in treating disease-states such as cancer |
| 03/31/2010 | EP2167464A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor) |
| 03/31/2010 | EP2166856A1 Chemical compounds |
| 03/31/2010 | EP1756054B1 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor |
| 03/31/2010 | CN101688020A Oxygen scavenging molecules, articles containing same, and methods of their use |
| 03/31/2010 | CN101687913A kallikrein 7 modulators |
| 03/31/2010 | CN101687794A oxime ester photoinitiators |
| 03/31/2010 | CN101687793A Crystal forms of saxagliptin and processes for preparing same |
| 03/31/2010 | CN101687792A Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 03/31/2010 | CN101687791A 5-lipoxygenase-activating protein (flap) inhibitors |
| 03/31/2010 | CN101687790A Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor) |
| 03/31/2010 | CN101687789A Novel inhibitors hepatitis c virus replication |
| 03/31/2010 | CN101687788A substituted indoles |
| 03/31/2010 | CN101687787A Inhibitors of iap |
| 03/31/2010 | CN101687786A Hydroxylamine compounds and methods of their use |
| 03/31/2010 | CN101683334A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 03/30/2010 | US7687665 2-(4-Chlorophenyl)-N-[(1R,2R)-2-(benzyloxy)cyclohexyl]-2-methylpropanamide; modulators of 11- beta hydroxyl steroid dehydrogenase type 1 and/or mineralocorticoid receptor |
| 03/30/2010 | US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction |
| 03/30/2010 | US7687642 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
| 03/30/2010 | US7687641 heating a mixture of anti-tricyclo[3.2.2.0]non-6-ene-endo-8, endo-9-dicarboxylic acid anhydride, 4-(trifluoromethyl)benzhydrazide, and ethanol at reflux, concetrating and recrystallizing; 4-Trifluoromethyl-N- (3,3a,4,4a,5,5a,6,6a,- octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol- 2(1H)-yl)-benzamide |
| 03/30/2010 | US7687535 Substituted 3-sulfur indoles |
| 03/30/2010 | US7687534 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 03/30/2010 | US7687529 treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; 1'-[3-(methylamino)-1-phenylpropyl]spiro[cyclohexane-1,3'-indol]-2'(1'H)-one |
| 03/30/2010 | US7687282 Detection of transmembrane potentials by optical methods |
| 03/30/2010 | US7687220 Oxime derivatives and use thereof as latent acids |
| 03/30/2010 | CA2572508C One pot synthesis of 2-oxazolidinone derivatives |
| 03/30/2010 | CA2364705C Optically pure camptothecin analogues |
| 03/30/2010 | CA2176183C 3-substituted oxindole derivatives as potassium channel modulators |
| 03/25/2010 | WO2010033043A1 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof |
| 03/25/2010 | WO2010032771A1 Amino acid derivative |
| 03/25/2010 | WO2010032257A1 Aryl indolyl sulfonamide compounds and their use as 5-ht6 ligands |
| 03/25/2010 | WO2010031852A1 Novel estrogen receptor ligands |
| 03/25/2010 | US20100076201 Carbazole Derivative and Method for Producing the Same |
| 03/25/2010 | US20100076051 Isoindolinone kinase inhibitors |
| 03/25/2010 | US20100076049 Novel oxindole derivative |
| 03/25/2010 | US20100076048 Isoindol Derivatives As EP4 Receptor Agonists |
| 03/25/2010 | US20100076047 Amorphous 1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol phosphate salt |
| 03/25/2010 | US20100076043 Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use |
| 03/25/2010 | US20100076041 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors |
| 03/25/2010 | US20100076010 Alpha 1a-adrenoceptor antagonists |
| 03/25/2010 | US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics |
| 03/25/2010 | US20100075963 Pharmaceutically Active Benzensulphonyl-Indols |
| 03/25/2010 | US20100075962 Indol derivatives, the method for preparing thereof and composition for the prevention and treatment of metabolic disorder containing the same as an active ingredient |
| 03/25/2010 | US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 03/25/2010 | US20100074867 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
| 03/25/2010 | US20100074845 Enhanced sensitivity carbon nanotubes as targeted photoacoustic molecular imaging agents |
| 03/25/2010 | US20100072887 Organoselenium materials and their uses in organic light emitting devices |
| 03/25/2010 | CA2737431A1 Amino acid derivative |
| 03/24/2010 | EP2166066A1 Additive for oils and lubricant containing the same |
| 03/24/2010 | EP2166001A1 Carbazole Derivative and Method for Producing the Same |
| 03/24/2010 | EP2165377A1 Organic light-emitting diodes containing carbene transition metal complex emitters and at least one compound selected from disilylcarbazoles, disilyldibenzofurans, disilyldibenzothiophenes, disilyldibenzophospholes, disilyldibenzothiophene s-oxides and disilyldibenzothiophene s,s-dioxides |
| 03/24/2010 | EP2164828A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation |
| 03/24/2010 | EP2164826A2 Dendritic photoactive compound comprising oxime ester and method for preparing the same |
| 03/24/2010 | EP1751104B1 Synthesis methods and intermediates for the manufacture of rizatriptan |